CSIMarket
 


Nutrastar International Inc.  (NUIN)
Other Ticker:  
 
 

NUIN's Revenue Growth by Quarter and Year

Nutrastar International's Revenue results by quarter and year




NUIN Revenue (in millions $) FY 2015 FY 2014 FY 2013 FY 2012
IV Quarter December - 12.29 13.13 12.30
III Quarter September 11.02 11.16 10.94 7.57
II Quarter June 13.24 13.00 11.87 10.04
I Quarter March 7.04 6.87 7.41 6.86
FY   31.30 43.32 43.35 36.77



NUIN Revenue third quarter 2015 Y/Y Growth Comment
Nutrastar International Inc. reported decrease in Revenue in the third quarter 2015 by -1.27% to $ 11.02 millions, from the same quarter in 2014.
The decrease in the third quarter 2015 Nutrastar International Inc.'s Revenue compares unfavorably to the Company's average Revenue growth of 7.13%.

Looking into third quarter 2015 results within Biotechnology & Pharmaceuticals industry 31 other companies have achieved higher Revenue growth. While Nutrastar International Inc.' s Revenue decline of -1.27% ranks overall at the positon no. 2380 in the third quarter 2015.




NUIN Revenue ( Y/Y Growth %) 2015
2014 2013 2012
IV Quarter December - -6.4 % 6.75 % -
III Quarter September -1.27 % 2.01 % 44.52 % -
II Quarter June 1.85 % 9.52 % 18.23 % -
I Quarter March 2.47 % -7.29 % 8.02 % -
FY   - -0.07 % 17.9 % -

Financial Statements
Nutrastar International's third quarter 2015 Revenue $ 11.02 millions NUIN's Income Statement
Nutrastar International's third quarter 2014 Revenue $ 11.16 millions Quarterly NUIN's Income Statement
New: More NUIN's historic Revenue Growth >>


NUIN Revenue (Quarter on Quarter Growth %)

2015
2014 2013 2012
IV Quarter December - 10.13 % 20.02 % 62.48 %
III Quarter September -16.78 % -14.15 % -7.83 % -24.6 %
II Quarter June 88.07 % 89.23 % 60.19 % 46.36 %
I Quarter March -42.72 % -47.68 % -39.76 % -
FY (Year on Year)   - -0.07 % 17.9 % -




Revenue third quarter 2015 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #32
Healthcare Sector #303
Overall #2380

Revenue Y/Y Growth Statistics
High Average Low
44.42 % 7.13 % -7.35 %
(Sep 30 2013)   (Mar 31 2014)
Revenue third quarter 2015 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #32
Healthcare Sector #303
Overall #2380
Revenue Y/Y Growth Statistics
High Average Low
44.42 % 7.13 % -7.35 %
(Sep 30 2013)   (Mar 31 2014)

Revenue by Quarter for the Fiscal Years 2012, 2013, 2014, 2015

Nutrastar International's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
89.39 % 13.07 % -47.69 %
(Jun 30 2014)  


NUIN's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2015 Nutrastar International Inc. reported fall in Revenue sequentially by -16.78% to $ 11.02 millions, from $ 13.24 millions achived a quarter before.

When you look into current slump at the III. Quarter, you must take into consideration, that commonly III. Quarter Revenue emerge weaker in contrast to the second quarter

Within Biotechnology & Pharmaceuticals industry 40 other companies have achieved higher Revenue quarter on quarter growth. While Nutrastar International's Revenue growth quarter on quarter, overall rank is 3689.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #41
Healthcare Sector #428
Overall #3689
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #41
Healthcare Sector #428
Overall #3689
Revenue Q/Q Growth Statistics
High Average Low
89.39 % 13.07 % -47.69 %
(Jun 30 2014)  


NUIN's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2015 Nutrastar International Inc. realized fall in Revenue from the previous quarter by -16.78% to $ 11.02 millions, from $ 13.24 millions released in the previous reporting period.

But that's not important issue, as III. Quarter Revenue frequently tend to slow in this quarter.

Within Biotechnology & Pharmaceuticals industry 40 other companies have achieved higher Revenue quarter on quarter growth. While Nutrastar International's Revenue growth quarter on quarter, overall rank is 3689.


Nutrastar International's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2015)
12 Months Ending
(Jun 30 2015)
12 Months Ending
(Mar 31 2015)
12 Months Ending
(Dec 31 2014)
12 Months Ending
(Sep 30 2014)
Cumulative Revenue 12 Months Ending $ 43.60 $ 43.74 $ 43.50 $ 43.33 $ 44.16
Y / Y Revenue Growth (TTM) -1.29 % -0.44 % 1.63 % -0.05 % 3.86 %
Year on Year Revenue Growth Overall Ranking # 2192 # 2459 # 2455 # 2455 # 870
Seqeuential Revenue Change (TTM) -0.33 % 0.55 % 0.41 % -1.89 % 0.52 %
Seq. Revenue Growth (TTM) Overall Ranking # 2021 # 2594 # 0 # 0 # 1897




Cumulative Revenue growth Comment
Nutrastar International's cumulative 12 months Revenue continue to decrease, but on the faster rate at -1.29% year on year, at Sep 30 2015 compare to the -0.44% decrease at Jun 30 2015. If the Nutrastar International's fiscal year would end at Sep 30 2015, annual Revenue would be $44 millions.

In the Healthcare sector 278 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2192, from total ranking in previous quarter at 2459.

Revenue TTM Q/Q Growth Statistics
High Average Low
17.89 %
6.06 %
-1.29 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 57
Healthcare Sector # 279
Overall # 2192

Revenue TTM Y/Y Growth Statistics
High Average Low
17.89 %
6.06 %
-1.29 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 57
Sector # 263
S&P 500 # 2021
Cumulative Revenue growth Comment
Nutrastar International's cumulative 12 months Revenue continue to decrease, but on the faster rate at -1.29% year on year, at Sep 30 2015 compare to the -0.44% decrease at Jun 30 2015. If the Nutrastar International's fiscal year would end at Sep 30 2015, annual Revenue would be $44 millions.

In the Healthcare sector 278 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 2192, from total ranking in previous quarter at 2459.

Revenue TTM Q/Q Growth Statistics
High Average Low
17.89 %
6.06 %
-1.29 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 57
Healthcare Sector # 279
Overall # 2192

Revenue TTM Y/Y Growth Statistics
High Average Low
17.89 %
6.06 %
-1.29 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 57
Sector # 263
S&P 500 # 2021




Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
NUIN's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for NUIN's Competitors
Revenue Growth for Nutrastar International's Suppliers
Revenue Growth for NUIN's Customers

You may also want to know
NUIN's Annual Growth Rates NUIN's Profitability Ratios NUIN's Asset Turnover Ratio NUIN's Dividend Growth
NUIN's Roe NUIN's Valuation Ratios NUIN's Financial Strength Ratios NUIN's Dividend Payout Ratio
NUIN's Roa NUIN's Inventory Turnover Ratio NUIN's Growth Rates NUIN's Dividend Comparisons



Companies with similar Revenue decrease for the quarter ending Sep 30 2015 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2015
Intercept Pharmaceuticals inc -0.09%$ -0.091 millions
Rafina Innovations Inc.-0.13%$ -0.131 millions
Phibro Animal Health Corporation-0.18%$ -0.180 millions
Arqule Inc-0.34%$ -0.338 millions
Msa Safety Incorporated-0.57%$ -0.568 millions
Achaogen, Inc.-0.97%$ -0.973 millions
Cas Medical Systems Inc-1.20%$ -1.199 millions
Quest Diagnostics Inc-1.26%$ -1.261 millions
Nutrastar International Inc.-1.31%$ -1.312 millions
Integra Lifesciences Holdings Corp-1.46%$ -1.459 millions
Cyteir Therapeutics Inc -1.87%$ -1.875 millions
Fonar Corporation-2.08%$ -2.080 millions
Pfizer Inc-2.22%$ -2.217 millions
Endo International Plc-2.38%$ -2.384 millions
American Shared Hospital Services-2.69%$ -2.687 millions
Cyclacel Pharmaceuticals Inc -2.72%$ -2.721 millions
Ufp Technologies Inc -2.73%$ -2.726 millions
Igc Pharma Inc -2.94%$ -2.938 millions
Teleflex Incorporated-2.94%$ -2.944 millions
Milestone Scientific Inc -2.96%$ -2.964 millions
West Pharmaceutical Services Inc -3.20%$ -3.203 millions
Conmed Corporation-3.30%$ -3.302 millions
Five Prime Therapeutics Inc -3.32%$ -3.317 millions
Standard Biotools Inc -3.35%$ -3.347 millions
Haemonetics Corporation-3.47%$ -3.466 millions
U s Stem Cell Inc -3.78%$ -3.783 millions
Mettler toledo International Inc -3.97%$ -3.965 millions
Allied Healthcare Products inc -4.32%$ -4.324 millions
Merck and Co Inc -4.58%$ -4.585 millions
Alkermes Plc -4.59%$ -4.587 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com